FeesSafety
Pluang+

US businesses added 86,000 jobs in October, beating expectations with broader hiring across industries.

Market News
04 Nov 2026, 15:29 WIB
Market Watch
View Source
Bullish
US businesses added 86,000 jobs in October, beating expectations with broader hiring across industries.

In October, US businesses created 86,000 new jobs, surpassing Wall Street's forecast of 75,000, according to ADP. This marks the second consecutive month of modest job growth, with more industries participating in hiring. The data suggests slight improvement in the sluggish US labor market, though employers remain cautious about adding large numbers of new positions. This trend may indicate gradual economic recovery but also signals ongoing uncertainty in the job market.

US businesses added 86,000 jobs in October, showing small signs of labor market improvement. For readers following the Industrials sector, here is Pluang's market snapshot as of Nov 04, 2026 20:11 WIB: out of 136 priced Industrials-sector US stocks, 72 rose and 57 fell. Notable movers include SPCX (SpaceX) at USD 130.97 with a 1-day change of -7.32%, INIO (INNIO N.V. Ordinary Shares) at USD 17.00 down 7.15%, and MOD (Modine Manufacturing Company) at USD 116.62 down 7.08%, with varied Pluang order activity and typical hold times.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
25 minutes ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
25 minutes ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
25 minutes ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
25 minutes ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
25 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App